PDF Publication Title:
Text from PDF Page: 015
Cancers 2018, 10, 144 15 of 15 29. Wein, L.; Loi, S. Mechanisms of resistance of chemotherapy in early-stage triple negative breast cancer (TNBC). Breast 2017, 34 (Suppl. 1), S27–S30. [CrossRef] [PubMed] 30. Simpson, G.R.; Relph, K.; Harrington, K.; Melcher, A.; Pandha, H. Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: Recent advances. Oncolytic Virother. 2016, 5, 1–13. [PubMed] 31. Liikanen, I.; Ahtiainen, L.; Hirvinen, M.L.; Bramante, S.; Cerullo, V.; Nokisalmi, P.; Hemminki, O.; Diaconu, I.; Pesonen, S.; Koski, A.; et al. Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients. Mol. Ther. 2013, 21, 1212–1223. [CrossRef] [PubMed] 32. Alonso, M.M.; Gomez-Manzano, C.; Jiang, H.; Bekele, N.B.; Piao, Y.; Yung, W.K.; Alemany, R.; Fueyo, J. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. Cancer Gene Ther. 2007, 14, 756–761. [CrossRef] [PubMed] 33. Holzmuller, R.; Mantwill, K.; Haczek, C.; Rognoni, E.; Anton, M.; Kasajima, A.; Weichert, W.; Treue, D.; Lage, H.; Schuster, T.; et al. YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma. Int. J. Cancer 2011, 129, 1265–1276. [CrossRef] [PubMed] 34. Kostova, Y.; Mantwill, K.; Holm, P.S.; Anton, M. An armed, YB-1-dependent oncolytic adenovirus as a candidate for a combinatorial anti-glioma approach of virotherapy, suicide gene therapy and chemotherapeutic treatment. Cancer Gene Ther. 2015, 22, 30–43. [CrossRef] [PubMed] 35. Bramante, S.; Koski, A.; Liikanen, I.; Vassilev, L.; Oksanen, M.; Siurala, M.; Heiskanen, R.; Hakonen, T.; Joensuu, T.; Kanerva, A.; et al. Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer. Oncoimmunology 2016, 5, e1078057. [CrossRef] [PubMed] 36. Jiang, H.; White, E.J.; Rios-Vicil, C.I.; Xu, J.; Gomez-Manzano, C.; Fueyo, J. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J. Virol. 2011, 85, 4720–4729. [CrossRef] [PubMed] 37. Yokoyama, T.; Iwado, E.; Kondo, Y.; Aoki, H.; Hayashi, Y.; Georgescu, M.M.; Sawaya, R.; Hess, K.R.; Mills, G.B.; Kawamura, H.; et al. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther. 2008, 15, 1233–1239. [CrossRef] [PubMed] 38. Egger, M.E.; McNally, L.R.; Nitz, J.; McMasters, K.M.; Gomez-Gutierrez, J.G. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum. Gene Ther. Clin. Dev. 2014, 25, 186–195. [CrossRef] [PubMed] 39. Borovjagin, A.V.; McNally, L.R.; Wang, M.; Curiel, D.T.; MacDougall, M.J.; Zinn, K.R. Noninvasive monitoring of MRFP1- and mcherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol. Imaging 2010, 9, 59–75. [CrossRef] [PubMed] 40. Wechman, S.L.; Rao, X.M.; Cheng, P.H.; Gomez-Gutierrez, J.G.; McMasters, K.M.; Zhou, H.S. Development of an oncolytic adenovirus with enhanced spread ability through repeated UV irradiation and cancer selection. Viruses 2016, 8, E167. [CrossRef] [PubMed] 41. Cheng, P.H.; Rao, X.M.; McMasters, K.M.; Zhou, H.S. Molecular basis for viral selective replication in cancer cells: Activation of CDK2 by adenovirus-induced cyclin E. PLoS ONE 2013, 8, e57340. [CrossRef] [PubMed] 42. Gomez-Gutierrez, J.G.; Souza, V.; Hao, H.Y.; Montes de Oca-Luna, R.; Dong, Y.B.; Zhou, H.S.; McMasters, K.M. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. Cancer Biol. Ther. 2006, 5, 875–883. [CrossRef] [PubMed] 43. Munshi, A.; Hobbs, M.; Meyn, R.E. Clonogenic cell survival assay. Methods Mol. Med. 2005, 110, 21–28. [PubMed] 44. Franken, N.A.; Rodermond, H.M.; Stap, J.; Haveman, J.; van Bree, C. Clonogenic assay of cells in vitro. Nat. Protoc. 2006, 1, 2315–2319. [CrossRef] [PubMed] 45. Menyhart, O.; Harami-Papp, H.; Sukumar, S.; Schafer, R.; Magnani, L.; de Barrios, O.; Gyorffy, B. Guidelines for the selection of functional assays to evaluate the hallmarks of cancer. Biochim. Biophys. Acta 2016, 1866, 300–319. [CrossRef] [PubMed] © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).PDF Image | Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy
PDF Search Title:
Temozolomide Enhances Triple-Negative Breast Cancer VirotherapyOriginal File Name Searched:
cancers-10-00144.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
| CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com | RSS | AMP |